2027 Medicare Part D changes: how to review your plan's costs

Medicare Part D is changing in 2027—and automatically renewing your current drug plan without checking it first could cost you more at the pharmacy.

As a pharmacist, I’m breaking down 5 things Medicare patients and caregivers should check before choosing their 2027 prescription drug coverage.

In this video:

• Why you should recheck every medication, strength, and formulation
• Drug tiers, prior authorizations, and other coverage restrictions
• 2027 Medicare Part D deductible and out-of-pocket changes
• New Medicare negotiated drug prices taking effect January 1, 2027
• Why “in-network” and “preferred” pharmacies aren't always the same
• What GLP-1 patients should check separately for 2027

Starting January 1, 2027, negotiated Medicare prices take effect for 15 additional high-cost Part D medications, including Ozempic, Rybelsus, Wegovy, Trelegy, Linzess, Vraylar, Xtandi, and others.

But here's an important distinction:

A Medicare negotiated price is NOT automatically the amount you will personally pay at the pharmacy.

Your specific Medicare plan, medication, formulation, drug tier, coverage requirements, pharmacy, and other factors can still affect your cost.

And if you take a GLP-1 medication, don't assume every Medicare GLP-1 headline means the same thing. The Medicare GLP-1 Bridge and Medicare's negotiated drug pricing are separate pathways with different rules.

MY 5-POINT PHARMACIST CHECKLIST:

• 1⃣ Check every medication and formulation
• 2⃣ Check its drug tier and coverage restrictions
• 3⃣ Compare total annual cost—not just the monthly premium
• 4⃣ Check whether your pharmacy is actually preferred
• 5⃣ Taking a GLP-1? Check those coverage pathways separately

If you have Medicare, what's more confusing: drug prices, choosing a plan, or figuring out what's actually covered?

Let me know in the comments—I may make your question my next video.